Back
Bright Minds Biosciences Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
55
DRUG
Bright Minds Biosciences
Last Price:
$32.58
Seasonality Move:
8.15%
7 Day Trial
ALL ACCESS PASS
$
7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report hereBright Minds Biosciences Stock Forecast
-
Over the next 52 weeks, Bright Minds Biosciences has on average historically risen by 667.7% based on the past 4 years of stock performance.
-
Bright Minds Biosciences has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Bright Minds Biosciences Stock Undervalued?The current Bright Minds Biosciences [DRUG] share price is $32.06. The Score for DRUG is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Bright Minds Biosciences Stock Go Up Next Year?
-
Over the next 52 weeks, Bright Minds Biosciences has on average historically risen by 667.7% based on the past 4 years of stock performance.
Bright Minds Biosciences Stock Rating
Buy
55
Bright Minds Biosciences (DRUG)
is a Buy
Is Bright Minds Biosciences overpriced?
-
Bright Minds Biosciences has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Bright Minds Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
brightmindsbio.com
52-Week Data
52-Week High:
79.02
52-Week Low:
0.93
Prediction Charts
Market Cap:
225.8M
Price in USD:
32.06
Volume:
25.9K
Beta:
-5.72
Technical Analysis
SMA50:
33.34
SMA100:
35.57
SMA200:
26.81
52-Wk Change:
2770.45%
Stock Predictions
-
Is Bright Minds Biosciences stock public?Yes, Bright Minds Biosciences is a publicly traded company.
-
What is the Bright Minds Biosciences stock quote today?The Bright Minds Biosciences stock price is 32.06 USD today.
-
How to buy Bright Minds Biosciences stock online?You can buy Bright Minds Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-21 | 32.60 | 31.89 | 33.63 | 31.10 |
Apr-22 | 32.67 | 33.50 | 33.77 | 32.36 |
Apr-23 | 34.50 | 34.10 | 35.94 | 33.52 |
Apr-24 | 34.69 | 33.42 | 34.73 | 33.23 |
Apr-25 | 33.80 | 32.71 | 33.82 | 32.00 |
Apr-28 | 33.09 | 32.18 | 33.47 | 31.64 |
Apr-29 | 33.12 | 30.89 | 33.12 | 30.37 |
Apr-30 | 30.01 | 30.70 | 31.40 | 28.70 |
May-1 | 31.13 | 30.62 | 31.28 | 29.82 |
May-2 | 31.33 | 32.17 | 32.18 | 31.03 |
May-5 | 32.08 | 31.21 | 32.43 | 30.15 |
May-6 | 32.75 | 29.02 | 32.75 | 29.02 |
May-7 | 31.75 | 30.10 | 31.75 | 29.75 |
May-8 | 30.57 | 32.06 | 32.34 | 29.59 |
Bright Minds Biosciences Earnings
Bright Minds Biosciences Earnings Report: Per Share Bright Minds Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Bright Minds Biosciences Forecast Revenue Growth
Bright Minds Biosciences Stock Analysis: Historical quarterly revenues per share for Bright Minds Biosciences and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.61 per share, and a decrease next year of $1.70 per share.
* Bright Minds Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.